Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTH in Idiopathic FSGS
NCT01155141Phase 4Completed
- Sponsor
- Stanford University
- Start
- Sep 2009
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of repository corticotropin injection in focal segmental glomerulosclerosis (FSGS), sponsored by Stanford University. Primary endpoints: 24 Hour Proteinuria at 6 months, Serum Creatinine at 6 months and 1 more. Started Sep 2009; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
focal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on NCT01155141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155141.